Regeneron Pharmaceuticals, Tarrytown, New York, USA.
Alzheimers Dement. 2022 Oct;18(10):1919-1929. doi: 10.1002/alz.12531. Epub 2022 Jan 3.
Increased activation of the contact system protein high molecular weight kininogen (HK) has been shown in plasma and cerebrospinal fluid of Alzheimer's disease (AD) patients, but its potential role in the brain has not been explored. We assessed HK levels in brain tissue from 20 AD patients and controls and modeled the effects of HK on microglia-like cells in culture. We show increased levels of HK in the hippocampus of AD patients, which colocalized with amyloid beta (Aβ) deposits and activated microglia. Treatment of microglia with HK led to cell clustering and elevated levels of phagocytosed Aβ. We demonstrate that microglia internalize HK and traffic it to lysosomes, which is accompanied by reduced activity of lysosomal cathepsins L and S. Our results suggest that HK accumulation in the AD hippocampus may alter microglial uptake and degradation of Aβ fibrils, possibly contributing to microglial dysfunction in AD.
已在阿尔茨海默病(AD)患者的血浆和脑脊液中发现接触系统蛋白高分子量激肽原(HK)的活性增加,但其在大脑中的潜在作用尚未得到探索。我们评估了 20 名 AD 患者和对照组脑组织中的 HK 水平,并在培养的类小胶质细胞中模拟了 HK 的作用。我们发现 AD 患者海马体中的 HK 水平升高,与淀粉样蛋白β(Aβ)沉积和激活的小胶质细胞共定位。用 HK 处理小胶质细胞会导致细胞聚集和吞噬的 Aβ水平升高。我们证明小胶质细胞内化 HK 并将其转运到溶酶体,这伴随着溶酶体组织蛋白酶 L 和 S 的活性降低。我们的结果表明,AD 海马体中 HK 的积累可能改变小胶质细胞对 Aβ纤维的摄取和降解,可能导致 AD 中小胶质细胞功能障碍。